Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration.

Leung SCY, Nielsen TO, Zabaglo LA, Arun I, Badve SS, Bane AL, Bartlett JMS, Borgquist S, Chang MC, Dodson A, Ehinger A, Fineberg S, Focke CM, Gao D, Gown AM, Gutierrez C, Hugh JC, Kos Z, Laenkholm AV, Mastropasqua MG, Moriya T, Nofech-Mozes S, Osborne CK, Penault-Llorca FM, Piper T, Sakatani T, Salgado R, Starczynski J, Sugie T, van der Vegt B, Viale G, Hayes DF, McShane LM, Dowsett M; International Ki67 in Breast Cancer Working Group of the Breast International Group and North American Breast Cancer Group (BIG-NABCG).

Histopathology. 2019 Aug;75(2):225-235. doi: 10.1111/his.13880. Epub 2019 Jul 8.

PMID:
31017314
2.

Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-stage HER2-positive Breast Cancer.

Kim RS, Song N, Gavin PG, Salgado R, Bandos H, Kos Z, Floris G, Eynden GGVD, Badve S, Demaria S, Rastogi P, Fehrenbacher L, Mamounas EP, Swain SM, Lawrence Wickerham D, Costantino JP, Paik S, Wolmark N, Geyer CE, Lucas PC, Pogue-Geile KL.

J Natl Cancer Inst. 2019 Mar 19. pii: djz032. doi: 10.1093/jnci/djz032. [Epub ahead of print]

PMID:
30888406
3.

Sculpting stable structures in pure liquids.

Emeršič T, Zhang R, Kos Ž, Čopar S, Osterman N, de Pablo JJ, Tkalec U.

Sci Adv. 2019 Feb 15;5(2):eaav4283. doi: 10.1126/sciadv.aav4283. eCollection 2019 Feb.

4.

Does integration of Magee equations into routine clinical practice affect whether oncologists order the Oncotype DX test? A prospective randomized trial.

Robertson SJ, Ibrahim MFK, Stober C, Hilton J, Kos Z, Mazzarello S, Ramsay T, Fergusson D, Vandermeer L, Mallick R, Arnaout A, Dent SF, Segal R, Sehdev S, Gertler S, Hutton B, Clemons M.

J Eval Clin Pract. 2019 Apr;25(2):196-204. doi: 10.1111/jep.13094. Epub 2019 Jan 23.

PMID:
30672056
5.

Active nematic emulsions.

Guillamat P, Kos Ž, Hardoüin J, Ignés-Mullol J, Ravnik M, Sagués F.

Sci Adv. 2018 Apr 6;4(4):eaao1470. doi: 10.1126/sciadv.aao1470. eCollection 2018 Apr.

6.

Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.

Hendry S, Salgado R, Gevaert T, Russell PA, John T, Thapa B, Christie M, van de Vijver K, Estrada MV, Gonzalez-Ericsson PI, Sanders M, Solomon B, Solinas C, Van den Eynden GGGM, Allory Y, Preusser M, Hainfellner J, Pruneri G, Vingiani A, Demaria S, Symmans F, Nuciforo P, Comerma L, Thompson EA, Lakhani S, Kim SR, Schnitt S, Colpaert C, Sotiriou C, Scherer SJ, Ignatiadis M, Badve S, Pierce RH, Viale G, Sirtaine N, Penault-Llorca F, Sugie T, Fineberg S, Paik S, Srinivasan A, Richardson A, Wang Y, Chmielik E, Brock J, Johnson DB, Balko J, Wienert S, Bossuyt V, Michiels S, Ternes N, Burchardi N, Luen SJ, Savas P, Klauschen F, Watson PH, Nelson BH, Criscitiello C, O'Toole S, Larsimont D, de Wind R, Curigliano G, André F, Lacroix-Triki M, van de Vijver M, Rojo F, Floris G, Bedri S, Sparano J, Rimm D, Nielsen T, Kos Z, Hewitt S, Singh B, Farshid G, Loibl S, Allison KH, Tung N, Adams S, Willard-Gallo K, Horlings HM, Gandhi L, Moreira A, Hirsch F, Dieci MV, Urbanowicz M, Brcic I, Korski K, Gaire F, Koeppen H, Lo A, Giltnane J, Rebelatto MC, Steele KE, Zha J, Emancipator K, Juco JW, Denkert C, Reis-Filho J, Loi S, Fox SB.

Adv Anat Pathol. 2017 Nov;24(6):311-335. doi: 10.1097/PAP.0000000000000161. Review.

7.

Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research.

Hendry S, Salgado R, Gevaert T, Russell PA, John T, Thapa B, Christie M, van de Vijver K, Estrada MV, Gonzalez-Ericsson PI, Sanders M, Solomon B, Solinas C, Van den Eynden GGGM, Allory Y, Preusser M, Hainfellner J, Pruneri G, Vingiani A, Demaria S, Symmans F, Nuciforo P, Comerma L, Thompson EA, Lakhani S, Kim SR, Schnitt S, Colpaert C, Sotiriou C, Scherer SJ, Ignatiadis M, Badve S, Pierce RH, Viale G, Sirtaine N, Penault-Llorca F, Sugie T, Fineberg S, Paik S, Srinivasan A, Richardson A, Wang Y, Chmielik E, Brock J, Johnson DB, Balko J, Wienert S, Bossuyt V, Michiels S, Ternes N, Burchardi N, Luen SJ, Savas P, Klauschen F, Watson PH, Nelson BH, Criscitiello C, O'Toole S, Larsimont D, de Wind R, Curigliano G, André F, Lacroix-Triki M, van de Vijver M, Rojo F, Floris G, Bedri S, Sparano J, Rimm D, Nielsen T, Kos Z, Hewitt S, Singh B, Farshid G, Loibl S, Allison KH, Tung N, Adams S, Willard-Gallo K, Horlings HM, Gandhi L, Moreira A, Hirsch F, Dieci MV, Urbanowicz M, Brcic I, Korski K, Gaire F, Koeppen H, Lo A, Giltnane J, Rebelatto MC, Steele KE, Zha J, Emancipator K, Juco JW, Denkert C, Reis-Filho J, Loi S, Fox SB.

Adv Anat Pathol. 2017 Sep;24(5):235-251. doi: 10.1097/PAP.0000000000000162. Review.

8.

Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.

Liu S, Chen B, Burugu S, Leung S, Gao D, Virk S, Kos Z, Parulekar WR, Shepherd L, Gelmon KA, Nielsen TO.

JAMA Oncol. 2017 Nov 9;3(11):e172085. doi: 10.1001/jamaoncol.2017.2085. Epub 2017 Nov 9.

9.

Cross-talk between topological defects in different fields revealed by nematic microfluidics.

Giomi L, Kos Ž, Ravnik M, Sengupta A.

Proc Natl Acad Sci U S A. 2017 Jul 18;114(29):E5771-E5777. doi: 10.1073/pnas.1702777114. Epub 2017 Jul 3.

10.

Architectural overlap between benign endocervix and pattern-A endocervical adenocarcinoma: Are all pattern-A tumors invasive?

Douglas G, Howitt BE, Schoolmeester JK, Schwartz L, Kos Z, Islam S, Djordjevic B, Parra-Herran C.

Pathol Res Pract. 2017 Jul;213(7):799-803. doi: 10.1016/j.prp.2017.03.008. Epub 2017 Mar 8.

PMID:
28554747
11.

The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancer.

He Y, Northey JJ, Pelletier A, Kos Z, Meunier L, Haibe-Kains B, Mes-Masson AM, Côté JF, Siegel PM, Lamarche-Vane N.

Oncogene. 2017 Jun 15;36(24):3490-3503. doi: 10.1038/onc.2016.492. Epub 2017 Jan 30.

12.

Basal biomarkers nestin and INPP4b identify intrinsic subtypes accurately in breast cancers that are weakly positive for oestrogen receptor.

Asleh-Aburaya K, Sheffield BS, Kos Z, Won JR, Wang XQ, Gao D, Wolber R, Gilks CB, Bernard PS, Chia SK, Nielsen TO.

Histopathology. 2017 Jan;70(2):185-194. doi: 10.1111/his.13038. Epub 2016 Sep 29.

PMID:
27402148
13.

Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group.

Denkert C, Wienert S, Poterie A, Loibl S, Budczies J, Badve S, Bago-Horvath Z, Bane A, Bedri S, Brock J, Chmielik E, Christgen M, Colpaert C, Demaria S, Van den Eynden G, Floris G, Fox SB, Gao D, Ingold Heppner B, Kim SR, Kos Z, Kreipe HH, Lakhani SR, Penault-Llorca F, Pruneri G, Radosevic-Robin N, Rimm DL, Schnitt SJ, Sinn BV, Sinn P, Sirtaine N, O'Toole SA, Viale G, Van de Vijver K, de Wind R, von Minckwitz G, Klauschen F, Untch M, Fasching PA, Reimer T, Willard-Gallo K, Michiels S, Loi S, Salgado R.

Mod Pathol. 2016 Oct;29(10):1155-64. doi: 10.1038/modpathol.2016.109. Epub 2016 Jul 1.

14.

Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration.

Leung SCY, Nielsen TO, Zabaglo L, Arun I, Badve SS, Bane AL, Bartlett JMS, Borgquist S, Chang MC, Dodson A, Enos RA, Fineberg S, Focke CM, Gao D, Gown AM, Grabau D, Gutierrez C, Hugh JC, Kos Z, Lænkholm AV, Lin MG, Mastropasqua MG, Moriya T, Nofech-Mozes S, Osborne CK, Penault-Llorca FM, Piper T, Sakatani T, Salgado R, Starczynski J, Viale G, Hayes DF, McShane LM, Dowsett M.

NPJ Breast Cancer. 2016 May 18;2:16014. doi: 10.1038/npjbcancer.2016.14. eCollection 2016.

15.

Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor.

Sheffield BS, Kos Z, Asleh-Aburaya K, Wang XQ, Leung S, Gao D, Won J, Chow C, Rachamadugu R, Stijleman I, Wolber R, Gilks CB, Myles N, Thomson T, Hayes MM, Bernard PS, Nielsen TO, Chia SK.

Breast Cancer Res Treat. 2016 Feb;155(3):483-90. doi: 10.1007/s10549-016-3689-z. Epub 2016 Feb 4.

PMID:
26846986
16.

Biomarker assessment and molecular testing for prognostication in breast cancer.

Kos Z, Dabbs DJ.

Histopathology. 2016 Jan;68(1):70-85. doi: 10.1111/his.12795. Review. Erratum in: Histopathology. 2016 May;68(6):946.

PMID:
26768030
17.

Relevance of saddle-splay elasticity in complex nematic geometries.

Kos Ž, Ravnik M.

Soft Matter. 2016 Jan 28;12(4):1313-23. doi: 10.1039/c5sm02417j.

PMID:
26610395
18.

Electric field generation of Skyrmion-like structures in a nematic liquid crystal.

Cattaneo L, Kos Ž, Savoini M, Kouwer P, Rowan A, Ravnik M, Muševič I, Rasing T.

Soft Matter. 2016 Jan 21;12(3):853-8. doi: 10.1039/c5sm01726b. Epub 2015 Nov 9.

19.

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.

Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G, Wienert S, Van den Eynden G, Baehner FL, Penault-Llorca F, Perez EA, Thompson EA, Symmans WF, Richardson AL, Brock J, Criscitiello C, Bailey H, Ignatiadis M, Floris G, Sparano J, Kos Z, Nielsen T, Rimm DL, Allison KH, Reis-Filho JS, Loibl S, Sotiriou C, Viale G, Badve S, Adams S, Willard-Gallo K, Loi S; International TILs Working Group 2014.

Ann Oncol. 2015 Feb;26(2):259-71. doi: 10.1093/annonc/mdu450. Epub 2014 Sep 11.

20.
21.

Predicting the Gleason sum of a patient with a prostate biopsy core Gleason ≤7 and a prostate biopsy core Gleason ≥8.

Heimrath OP, Kos Z, Belanger EC, Cagiannos I, Morash C, Gerridzen RG, Lavallée LT, Preston MA, Witiuk K, Breau RH.

Can Urol Assoc J. 2014 Jul;8(7-8):E476-80. doi: 10.5489/cuaj.1737.

22.

Fallopian tube high-grade serous carcinoma with intramucosal spread and presenting as a malignancy on pap smear.

Kos Z, Broaddus RR, Djordjevic B.

Int J Gynecol Pathol. 2014 Jul;33(4):443-8. doi: 10.1097/PGP.0b013e31829c728b.

PMID:
24901407
23.

Fluorescence in situ hybridization as an adjunct tool in the diagnosis of primary and metastatic renal cell carcinoma in fine needle aspiration specimens.

Kos Z, Williams PA, Belanger EC, Mai KT.

Diagn Cytopathol. 2014 Dec;42(12):1013-23. doi: 10.1002/dc.23154. Epub 2014 Apr 1.

PMID:
24692327
24.

Developing a new generation of breast cancer clinical gene expression tests.

Kos Z, Nielsen TO.

Breast Cancer Res. 2014 Jul 7;16(4):103. doi: 10.1186/bcr3688.

25.
26.

Mixed low- and high-grade papillary urothelial carcinoma: histopathogenetic and clinical significance.

Mai KT, Flood TA, Williams P, Kos Z, Belanger EC.

Virchows Arch. 2013 Oct;463(4):575-81. doi: 10.1007/s00428-013-1456-7. Epub 2013 Aug 4.

PMID:
23913166
27.

A rare case of anaplastic variant of diffuse large B-cell lymphoma presenting as a lung primary.

Kos Z, Burns BF, Gomes MM, Sekhon HS.

Int J Surg Pathol. 2014 Apr;22(2):167-71. doi: 10.1177/1066896913491318. Epub 2013 Jun 17.

PMID:
23775019
28.

Malignant peripheral nerve sheath tumor arising in a traumatic neuroma: a case report.

Kos Z, Robertson SJ, Purgina BM, Verma S, Gravel DH.

Hum Pathol. 2013 Oct;44(10):2360-4. doi: 10.1016/j.humpath.2013.02.020. Epub 2013 May 21.

PMID:
23701941
29.

Low-grade versus high-grade chromophobe renal cell carcinoma.

Bradshaw SH, Kos Z, Nguyen BN, Robertson SJ, Belanger EC, Mai KT.

Am J Surg Pathol. 2011 Apr;35(4):620; author reply 620-1. doi: 10.1097/PAS.0b013e31820f14d7. No abstract available.

PMID:
21358300
30.

Antimetabolic activity of L-ascorbic acid in human and animal tumors.

Pavelić K, Kos Z, Spaventi S.

Int J Biochem. 1989;21(8):931-5.

PMID:
2583359
31.

Supplemental Content

Support Center